Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03891472 | Clinical Phase II Clinical Study Evaluating the Toxicity and Efficacy of mFOLFIRINOX Associated With SBRT (Stereotactic Radiotherapy) in Patients With Unresectable Locally Advanced Pancreatic Cancer | completed | Phase 2 | 40 | Medical University of SilesiaOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT02106884 | Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel(QOLINPAC) | completed | Phase 2 | 146 | Universitaire Ziekenhuizen KU LeuvenOTHER |
| 1 |
| Nov 6, 2019 |
| clinicaltrials |
| NCT00005858 | LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer | completed | Phase 1 | 25 | University of Maryland, BaltimoreOTHER | 1 | Nov 4, 2019 | clinicaltrials |
| NCT02021500 | A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. | completed | — | 40 | CelgeneINDUSTRY | 9 | Nov 1, 2019 | clinicaltrials |
| NCT00379639 | A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors | completed | Phase 1 | 36 | CelgeneINDUSTRY | 1 | Oct 30, 2019 | clinicaltrials |
| NCT02620800 | Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer(FABLOx) | completed | Phase 1 | 12 | CelgeneINDUSTRY | 1 | Oct 22, 2019 | clinicaltrials |
| NCT00733746 | Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | completed | Phase 2 | 123 | Alliance for Clinical Trials in OncologyOTHER | 2 | Oct 21, 2019 | clinicaltrials |
| NCT02043730 | Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.(GAP) | completed | Phase 2 | 124 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Oct 9, 2019 | clinicaltrials |
| NCT02148549 | Neoadjuvant FIRINOX for Borderline Resectable Pancreatic Cancer - a Pilot Study(FIRINOX) | completed | Phase 1 | 10 | Wakayama Medical UniversityOTHER | 1 | Oct 7, 2019 | clinicaltrials |
| NCT01806675 | 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | completed | Phase 1 / Phase 2 | 25 | Sanjiv Sam GambhirOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | completed | Phase 1 | 66 | TG Therapeutics, Inc.INDUSTRY | 1 | Oct 2, 2019 | clinicaltrials |
| NCT02362048 | ACP-196 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Pancreatic Cancer(KEYNOTE144) | completed | Phase 2 | 77 | Acerta Pharma BVINDUSTRY | 1 | Oct 1, 2019 | clinicaltrials |
| NCT02374255 | Improving Goals of Care Discussion in Advanced Cancer Patients | completed | N/A | 265 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT03567863 | Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles(HISTOPAN) | completed | N/A | 60 | Société Française d'Endoscopie DigestiveOTHER | 1 | Oct 1, 2019 | clinicaltrials |
| NCT04109495 | Usefulness of Smartphone Application for Improving Nutritional Status of Pancreatic Cancer Patients | completed | N/A | 40 | Yonsei UniversityOTHER | 1 | Sep 30, 2019 | clinicaltrials |
| NCT01058746 | Randomized Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection | completed | N/A | 331 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT03566056 | Early Recovery Outcomes After Standardized Fast-track Whipples Procedure | completed | — | 100 | Eske Kvanner AasvangOTHER | 1 | Sep 25, 2019 | clinicaltrials |
| NCT01505530 | A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer | completed | Phase 2 | 125 | Eli Lilly and CompanyINDUSTRY | 5 | Sep 18, 2019 | clinicaltrials |
| NCT01028495 | A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer | completed | Phase 2 | 31 | Rexahn Pharmaceuticals, Inc.INDUSTRY | 2 | Sep 12, 2019 | clinicaltrials |
| NCT02718859 | Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 60 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT02894944 | Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer(Theragene) | completed | Phase 1 | 9 | Seoul National University HospitalOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT03008304 | High-activity Natural Killer Immunotherapy for Small Metastases of Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT03331055 | PENS or TENS for Pain in Pancreatic Cancer | completed | N/A | 36 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT02296736 | The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan | completed | — | 422 | University Hospital Plymouth NHS TrustOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT02999672 | A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors(KAMELEON) | completed | Phase 2 | 20 | Hoffmann-La RocheINDUSTRY | 4 | Aug 28, 2019 | clinicaltrials |
| NCT03021668 | Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections | completed | N/A | 124 | Johns Hopkins UniversityOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT(GCC 1324) | completed | Early Phase 1 | 8 | University of Maryland, BaltimoreOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT02002806 | Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control | completed | N/A | 150 | Indiana UniversityOTHER | 1 | Aug 16, 2019 | clinicaltrials |
| NCT02583477 | Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma | completed | Phase 1 / Phase 2 | 23 | AstraZenecaINDUSTRY | 2 | Aug 14, 2019 | clinicaltrials |
| NCT02734160 | A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer | completed | Phase 1 | 37 | Eli Lilly and CompanyINDUSTRY | 5 | Aug 5, 2019 | clinicaltrials |
| NCT02841800 | Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis | completed | N/A | 5 | National Taiwan University HospitalOTHER | 0 | Aug 5, 2019 | clinicaltrials |
| NCT02333279 | Cancer Development In Organ Transplant Recipients | completed | — | 1,800 | University of ZurichOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT01858883 | Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 55 | Incyte CorporationINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02973672 | Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas | completed | Phase 1 / Phase 2 | 75 | SurgimabINDUSTRY | 1 | Jul 18, 2019 | clinicaltrials |
| NCT02695966 | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer(EVIS) | completed | — | 20 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jul 16, 2019 | clinicaltrials |
| NCT03150615 | Enteral Nutrition After Pancreaticoduodenectomy | completed | N/A | 120 | Nanjing Medical UniversityOTHER | 1 | Jul 12, 2019 | clinicaltrials |
| NCT01664169 | Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303 | completed | — | 307 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 2, 2019 | clinicaltrials |
| NCT01603004 | Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors | completed | — | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT02283372 | Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic Cancer | completed | Phase 1 | 30 | Washington University School of MedicineOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01132755 | Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage | completed | Phase 2 | 112 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT02295956 | Preoperative Rehabilitation During Neoadjuvant Therapy for Pancreatic Cancer | completed | Early Phase 1 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03532347 | Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study)(SharkBITE) | completed | N/A | 108 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 1 | Jun 10, 2019 | clinicaltrials |
| NCT03973736 | Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study(RevRadPAC) | completed | — | 316 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 4, 2019 | clinicaltrials |
| NCT01893801 | Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA | completed | Phase 1 / Phase 2 | 25 | Pancreatic Cancer Research TeamOTHER | 1 | May 29, 2019 | clinicaltrials |
| NCT00030732 | Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 3 | 319 | Swiss Cancer InstituteOTHER | 4 | May 15, 2019 | clinicaltrials |
| NCT02000999 | Diagnosis of Bile Duct Strictures | completed | — | 110 | Washington University School of MedicineOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT01128296 | Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas | completed | Phase 1 / Phase 2 | 35 | Amer ZureikatOTHER | 1 | May 1, 2019 | clinicaltrials |
| NCT01088815 | Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas | completed | Phase 2 | 98 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT00923299 | Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine(THERAPY) | completed | Phase 1 / Phase 2 | 33 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Apr 16, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Nov 13, 2019source: clinicaltrials